Weak CAPA Programs Hit Globally by FDA Warnings
Life sciences companies around the world better make sure their Corrective and Preventive Action (CAPA) plans are in good shape before an inspector comes calling.
Life sciences companies around the world better make sure their Corrective and Preventive Action (CAPA) plans are in good shape before an inspector comes calling.
A trio of FDA 510(k) guidances demonstrate how important it is for medical device manufacturers to get a firm grip on document management and change control – especially when working within the Third Party (TP) Review Program or trying to determine if a medical device change warrants a new 510(k). The agency is attempting to make it easier on device makers if they understand how to work within the new system.
If working with the FDA sometimes feels like reading tea leaves the Quarterly Update on Medical Device Performance Goals gives us more than our usual share of relatively hard data.
It's time to get your compliance programs in order to meet some looming international regulatory compliance demands, experts including former Food and Drug Administration officials say. Having a firm grip on quality management (QMS) processes - especially document management and change control - will be critical to comply with such a disparate group of regulations working with so many regulatory bodies.
Here's what life sciences companies moving their quality and compliance management tools to the cloud can expect.
FDA CDRH or Center for Devices and Radiological Health Director Jeff Shur [...]
Medical device warning letters and domestic inspections continue to show a slow [...]
The FDA and Intercenter Consultations Just a few short weeks ago, Robert Califf, [...]
Our latest round of warning letters emphasize the importance for medical device [...]
FDA will be taking applications starting Sept 1, 2015, looking for makers of cla [...]